Cleared Abbreviated

K062834 - OSTEON

K062834 is an FDA 510(k) clearance for OSTEON, manufactured by Genoss Co., Ltd.. The device is a Class 2 Dental device with product code LYC cleared through the Abbreviated 510(k) pathway after a 215-day FDA review.

K062834 · Genoss Co., Ltd. · Dental device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2007
Decision
215d
Days
Class 2
Risk

K062834 is an FDA 510(k) clearance for the OSTEON, MODELS GBG0305, GBG0510, GBG1020, GBG2030, GBG3040, GBG4050. Classified as Bone Grafting Material, Synthetic (product code LYC), Class II - Special Controls.

Submitted by Genoss Co., Ltd. (Laguna Niguel, US). The FDA issued a Cleared decision on April 24, 2007 after a review of 215 days - an extended review cycle.

This device falls under the Dental FDA review panel, regulated under 21 CFR 872.3930 - the FDA dental device regulatory framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.

View all Genoss Co., Ltd. devices

FDA 510(k) Submission Details - K062834

510(k) Number K062834 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 21, 2006
Decision Date April 24, 2007
Days to Decision 215 days
Submission Type Abbreviated
Review Panel Dental (DE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
88d slower than avg
Panel avg: 127d · This submission: 215d
Pathway characteristics
Standards-based clearance path.

LYC Device Classification - Class 2, Special Controls

Product Code LYC Bone Grafting Material, Synthetic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 872.3930
Definition A Synthetic Bone Grafting Material Is Synthetically-derived Device, Such As Hydroxylapatite, Intended To Fill, Augment, Or Reconstruct Periodontal And Or Bony Defects Of The Upper Or Lower Jaw.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Dental devices follow this clearance model.

Regulatory Peers - LYC Bone Grafting Material, Synthetic

All 73
Devices cleared under the same product code (LYC) and FDA review panel - the closest regulatory comparables to K062834.
OSTEOGRAF/D-300
K072052 · Dentsply International, Inc. · Aug 2007
OSTEOGRAF/D-700
K072056 · Dentsply International, Inc. · Aug 2007
OSTEOGRAF/LD-300
K072057 · Dentsply International, Inc. · Aug 2007
PERIOGLAS PUTTY-BIOACTIVE BONE GRAFT GEL
K063596 · Novabone Products, LLC · Feb 2007
NOVABONE DENTAL PUTTY-BIOACTIVE SYNTHETIC BONE GRAFT
K063549 · Novabone Products, LLC · Feb 2007
PERIOGLAS BONE GRAFT PARTICULATE
K053387 · Novabone Products, LLC · Feb 2006